General Information of the Compound
Compound ID
CP0541474
Compound Name
2-methyl-3-[(3-methylphenyl)methyl]-7-piperazin-1-ylimidazo[4,5-b]pyridine
    Show/Hide
Structure
Formula
C19H23N5
Molecular Weight
321.428
Canonical SMILES
Cc1nc2c(ccnc2n1Cc1cccc(C)c1)N1CCNCC1
    Show/Hide
InChI
InChI=1S/C19H23N5/c1-14-4-3-5-16(12-14)13-24-15(2)22-18-17(6-7-21-19(18)24)23-10-8-20-9-11-23/h3-7,12,20H,8-11,13H2,1-2H3
    Show/Hide
InChIKey
UAJLXVJPBBETMH-UHFFFAOYSA-N
Physicochemical Property
logP
2.50604
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
45.98
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145950947
ChEMBL ID
CHEMBL4172073
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 26 nM
   TI
   LI
   LO
   TS